Since the beginning of mpox monitoring in 2022, and as of 31 July 2024, over 100 000 confirmed cases of mpox due to monkeypox virus (MPXV) clade I and clade II, including over 200 deaths among confirmed cases, have been reported by more than 120 countries globally.
Quelle: European Centre for Disease Prevention and Control
Titelbild/Grafik: European Centre for Disease Prevention and Control (ECDC)
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Aktuelles von European Centre for Disease Prevention and Control
- Slow increases in COVID-19 observed across EU/EEA as a new variant emerges
- Epidemiological update: SARS-CoV-2 and NB.1.8.1 variant assessment
- Rapid risk assessment module enhances emergency response capacity of field epidemiology fellows
- Strengthening health resilience through simulation exercises and after-action reviews
- Tackling Antimicrobial Resistance in Moldova: An interview with Nadejda Morarescu
- Record-high rates of STEC and Listeria infections in the EU/EEA in 2023
- Diphtheria strain involved in outbreaks among vulnerable populations across Europe between 2022 and 2025
- Gulf Health Council and Gulf CDC visit ECDC
- Risk ranking of epidemic-prone diseases in the Northern African Regional Coordination Centre in Egypt
- Postcard from the field: deployment to South Sudan through the WHO Global Outbreak Alert and Response Network (GOARN)
